Medixcel Pharmaceuticals Private Limited
About Medixcel Pharmaceuticals Private Limited
Data last updated:
Medixcel Pharmaceuticals Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It was incorporated on 21 June 2023.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U46497UP2023PTC184351. Its GSTIN is 09AAQCM9841G1ZT (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Avdhesh Kumar Dwivedi and Upendra Dwivedi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sector 120, Noida, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹73.77 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹11.35 Lakh (net margin -15.4%) and EBITDA of -₹11.15 Lakh (EBITDA margin -15.1%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressE 105 1st Floor, Rg Residency Sector 120, Noida, Uttar Pradesh, India – 201301
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medixcel Pharmaceuticals Private Limited
The main business activity of Medixcel Pharmaceuticals is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medixcel Pharmaceuticals Private Limited FY 2025 filings available
Medixcel Pharmaceuticals Private Limited reported revenue of ₹73.77 Lakh (up 222% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Medixcel Pharmaceuticals Private Limited
Revenue rose 222% in the latest year. EBITDA fell 62% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Medixcel Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹11.15 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹11.35 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Medixcel Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -15.1% | •••• |
| Net Profit Margin | -15.4% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medixcel Pharmaceuticals are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Medixcel Pharmaceuticals Private Limited
Medixcel Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Avdhesh Kumar Dwivedi Also directs: Fifthgen Tech Solution LLP | Director | 21 Jun 2023 | 3 Years 4 Months | Current |
| Upendra Dwivedi | Director | 21 Jun 2023 | 3 Years 4 Months | Current |
Peer Comparison of Medixcel Pharmaceuticals Private Limited
Medixcel Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rbco Pharmaceuticals Private Limited | ₹74.57 Lakh (FY 2024) | •••• | •••• | 88.0% | •••• | Raipur, Chhattisgarh, India |
| Remedia Pharmaceuticals Private Limited | ₹74.56 Lakh (FY 2025) | •••• | •••• | 7.0% | •••• | Thane, Maharashtra, India |
| Stardevson Pharmaceuticals (OPC) Private Limited | ₹74.47 Lakh (FY 2025) | •••• | •••• | 15.0% | •••• | Bilaspur, Chhattisgarh, India |
| Aprikose Pharmaceuticals Private Limited | ₹74.18 Lakh (FY 2019) | •••• | •••• | 32.0% | •••• | Jaipur, Rajasthan, India |
| Marquess Genetica Pharmaceuticals Private Limited | ₹73.82 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Ernakulam, Kerala, India |
| Medixcel Pharmaceuticals Private Limited this company | ₹73.77 Lakh (FY 2025) | •••• | •••• | 222.0% | •••• | Noida, Uttar Pradesh, India |
| Sunovion Pharmaceuticals (India) Private Limited | ₹73.66 Lakh (FY 2025) | •••• | •••• | 80.0% | •••• | Mumbai, Maharashtra, India |
| Sickcure Pharmaceuticals Private Limited | ₹73.64 Lakh (FY 2024) | •••• | •••• | -19.0% | •••• | Paontasahib, Himachal Pradesh, India |
| Rholence Pharmaceuticals Private Limited | ₹73.59 Lakh (FY 2024) | •••• | •••• | 16.0% | •••• | Nagpur, Maharashtra, India |
| Riksan Pharmaceuticals Private Limited | ₹73.55 Lakh (FY 2025) | •••• | •••• | 25.0% | •••• | Mangalore, Karnataka, India |
| Mayaan Pharmaceuticals Private Limited | ₹73.45 Lakh (FY 2024) | •••• | •••• | 76.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Medixcel Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Medixcel Pharmaceuticals Private Limited
Medixcel Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Medixcel Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Medixcel Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medixcel Pharmaceuticals Private Limited
Medixcel Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Avdhesh Kumar Dwivedi was appointed as Director on 21 Jun 2023.
Credit Ratings, Litigation & Regulatory Alerts for Medixcel Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medixcel Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medixcel Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medixcel Pharmaceuticals Private Limited
Medixcel Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAQCM9841G1ZT | Uttar Pradesh | Active | 24 Jul 2023 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medixcel Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medixcel Pharmaceuticals Private Limited
Medixcel Pharmaceuticals is an active private limited company based in Noida, Uttar Pradesh, India. It was incorporated on 21 June 2023 (3+ years old) and is registered under CIN U46497UP2023PTC184351.
Medixcel Pharmaceuticals reported revenue of ₹73.77 Lakh for FY 2025 (up 222% YoY).
Medixcel Pharmaceuticals has 2 current directors:
- Avdhesh Kumar Dwivedi - Director
- Upendra Dwivedi - Director
Medixcel Pharmaceuticals reported a net loss of ₹11.35 Lakh (net margin -15.4%) and EBITDA of -₹11.15 Lakh (EBITDA margin -15.1%) for FY 2025, as per its filed financial statements.
The GSTIN of Medixcel Pharmaceuticals is 09AAQCM9841G1ZT, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Medixcel Pharmaceuticals is U46497UP2023PTC184351. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medixcel Pharmaceuticals was incorporated on 21 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Medixcel Pharmaceuticals by revenue are Rbco Pharmaceuticals Private Limited, Remedia Pharmaceuticals Private Limited, Stardevson Pharmaceuticals (OPC) Private Limited, Aprikose Pharmaceuticals Private Limited, Marquess Genetica Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Avdhesh Kumar Dwivedi was appointed as Director on 21 Jun 2023. Upendra Dwivedi was appointed as Director on 21 Jun 2023.
The registered office of Medixcel Pharmaceuticals is at E 105 1st Floor, Rg Residency Sector 120, Noida, Uttar Pradesh, India – 201301.
Medixcel Pharmaceuticals has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh.